Typhim VI 25 MCG/0.5 ML syrng 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJH8L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $143,060
Award facts
- Contract value 100% obligated
- $143,060.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $143,060 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 14, 2026, with a completion date of January 15, 2026, for TYPHIM VI 25 MCG/0.5 ML vaccine syringes. This firm fixed-price, non-set-aside contract is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s larger indefinite delivery contract with DLA Troop Support Medical, a $999,999,999 prime vendor agreement that extends through December 2031 and serves as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems globally.
AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated extensive capability in fulfilling federal medical procurement requirements through open competition. The company's portfolio with the Defense Logistics Agency encompasses a comprehensive range of pharmaceutical products, vaccines, and medical supplies across multiple therapeutic domains. This award reflects the company's ongoing role as a critical vendor supporting military treatment facilities and other federal healthcare systems through the DLA's pharmaceutical supply chain, with the parent company Cencora maintaining significant prime contract authority for coordinating these medical product deliveries.
Quick answers
Who was awarded contract SPE2DR26FJH8L?
SPE2DR26FJH8L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FJH8L worth?
The government has obligated $143,060 on SPE2DR26FJH8L.
Is contract SPE2DR26FJH8L an order under another contract?
Yes. SPE2DR26FJH8L is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH8L competed?
The extent of competition for SPE2DR26FJH8L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award